In this session, Mitchell Clark, MD, MPH, reviews the current evidence surrounding ovarian cancer screening and its implications for clinical practice. The discussion will address population-level data, screening limitations, risk stratification, and existing guideline recommendations, with an emphasis on how clinicians can apply this evidence to patient counseling and shared decision-making. This talk aims to clarify common areas of confusion and support informed, evidence-based approaches to ovarian cancer screening in clinical care.

Mitchell Clark, MD, MPH, is a physician at Yale School of Medicine with expertise in preventive medicine, population health, and evidence-based screening strategies. His work focuses on the evaluation and implementation of cancer screening and prevention practices, with particular attention to translating population-level data into informed clinical decision-making. Dr. Clark brings a public health–informed perspective to ovarian cancer screening, emphasizing risk assessment, current evidence, and the clinical implications for patient counseling and care.